GUNA-DIUR

Manufacturer
Guna spa
Effective date
2018-12-21
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:11:13

Label at a glance#

ProductGUNA-DIUR
Active ingredientAMILORIDE, APIS MELLIFERA, BERBERIS VULGARIS FRUIT, HYDROCHLOROTHIAZIDE, SUS SCROFA PITUITARY GLAND, HIERACIUM PILOSELLA FLOWERING TOP, SOLIDAGO VIRGAUREA FLOWERING TOP, SPIRONOLACTONE
Label structure18 sections

Indications and uses

1.1 Temporary relief of fluid retention 1.2 Tissue swelling and related disconforts

Dosage and administration

Adults: 20 drops in a little water, 2 times per day for an avarage of two months. Stop use and ask a doctor if symptoms persist more than 5 days. Administration may very according to individual needs. GUNA-DIUR may be used together with other homeopthic medicines.

Storage and handling

16.1. NDC 17089-260-18 Oral Solution/Drops 30 mL 16.2. Store at 20-25°C (68-77° F). Excursions permitted between 15°-30°C (59°-86°F).

Label contents#

Full prescribing information#

1. INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION


1.1 Temporary relief of fluid retention
1.2 Tissue swelling and related disconforts




2. DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Adults: 20 drops in a little water, 2 times per day for an avarage of two months.

Stop use and ask a doctor if symptoms persist more than 5 days.

Administration may very according to individual needs.

GUNA-DIUR may be used together with other homeopthic medicines.

3. DOSAGE FORMS AND STRENGTHS

DOSAGE FORMS & STRENGTHS SECTION

3.1. 30 ml Bottle dropper container contains:
Active ingredients: Amiloride 4X 0.006 ml, Apis Mellifica 2X 0.626 ml, Berberis Vulgaris T 0.314 ml, Hydrochlorothiazide 4X 0.006 ml, Hypophysis 12X 6.314 ml, Mouse-Ear Hawkweed T 6.314 ml, Solidago Virgaurea T 0.314 ml, Spironolactone 4X 0.006 ml.
Inactive Ingredient: Ethylic Alcohol 30%


4. CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

4.1. There is no history of hypersensitivity to GUNA-DIUR. However, do not use if you are hypersensitive to any of the active ingredients of Guna-Diur.

5. WARNINGS AND PRECAUTIONS

WARNINGS AND PRECAUTIONS SECTION

5.1. GUNA-DIUR is contraindicated in patients with anuria and in patients with a history of hypersensitivity to Spironolactone, Amiloride, or Hydrocholorthiazide.

5.2. Use with caution in patients taking diuretic medications.

5.3 Keep out of reach of children.


6. ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

6.1.    None known (see CONTRAINDICATIONS for hypersensitivity information).

7. DRUG INTERACTIONS

DRUG INTERACTIONS SECTION

7.1.    None Known

8. USE IN SPECIFIC POPULATIONS

USE IN SPECIFIC POPULATIONS SECTION

8.1. Pregnancy: Pregnancy category C. Animal reproduction studies have not been conducted with GUNA-DIUR. GUNA®- DIUR should not be given to a pregnant woman.

8.2. Lactation: It is not known whether any of the ingredients in GUNA- DIUR are secreted in human milk. However, since many drugs are secreted in human milk, caution should be exercised when GUNA- DIUR is administered to a nursing woman.

8.3. Pediatric use: Safety and effectiveness in pediatric patients have not been established.


8.4. Geriatric use: No restrictions.

9. DRUG ABUSE AND DEPENDENCE

DRUG ABUSE AND DEPENDENCE SECTION

9.1.    No Known.

10. OVERDOSAGE

OVERDOSAGE SECTION

10.1.    No Known.

11. DESCRIPTION

DESCRIPTION SECTION

11. 1 GUNA-DIUR is a homeopathic medicine indicated for the temporary relief of fluid retention, tissue swelling and related disconforts.

12. CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

12.1. GUNA-DIUR exerts a diuretic effect. This is based on homeopthica Materia Medica and homeopathic principles.

12.2. Pharmacodynamics
Not applicable to homeopthic medicinal products.

12.3. Pharmacokinetics

Not applicable to homeopthic medicinal products.

13. NONCLINICAL TOXICOLOGY

NONCLINICAL TOXICOLOGY SECTION

13.1. Not available.


14. CLINICAL STUDIES

CLINICAL STUDIES SECTION

14.1. GUNA-DIUR efficacy is not supported by clinical studies. It is based on homeopathic Materia Medica and scientific literature.

15. REFERENCES

REFERENCES SECTION

15.1.    H.H. Reckeweg. Homeopathic Materia Medica.  Aurelia Verlag.
15.2.    Boericke,  William,  Materia  Medica  with  Reperatory,  1927,  ninth edition

16. HOW SUPPLIED/STORAGE AND HANDLING

STORAGE AND HANDLING SECTION

16.1. NDC 17089-260-18 Oral Solution/Drops 30 mL

16.2. Store at 20-25°C (68-77° F). Excursions permitted between 15°-30°C (59°-86°F).

17. PATIENT COUNSELING INFORMATION

INFORMATION FOR PATIENTS SECTION

17.1.    Patients should be informed about Homeopathy and the main differences with conventional clinical approaches.

PACKAGE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

5USPIL-GUNA-DIUR-rev05-10-185USPIL-GUNA-DIUR-rev05-10-18

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1Product name320260303
1199f4b7-b537-466c-9a1c-cb09131e9f8bProduct name120251117
d335cba1-5b36-51c8-120a-594ec9d05330Product name520251114
e1a63b6e-1877-c2c1-01a3-03ea2817aa6fProduct name320251027
b15e9aa6-d523-ca97-480e-570e0543a342Product name420251024
25f5e2cf-3572-477b-994c-aa692751e5a8Product name220250616
96816964-c075-ffa7-b7b8-d8570411a3b9Product name720250305
162cbc9d-ecc3-72ba-af9f-c76e2756ef54Product name320221207
9b303cd4-3186-2454-5706-3137e8b2dfd2Product name420221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0eaProduct name120200505
a8e65197-7914-7acf-c7ec-914d53819b34Product name320190624
8b67f333-47d1-8464-7ce4-406d3dbb295fProduct name720190618
89a57420-ab44-5323-14f9-595159145f9bProduct name220190612
c27b049d-3258-48cf-ebe5-08c236ae78e2Product name320190610
00fc2cf9-672f-3e0b-6afa-43cbc864d058Product name420180613
15b375b1-89c7-9594-80df-5a8c8864aee0Product name320180108
a7349398-661d-d9fc-46df-7e128bbd61d9Product name520171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3dProduct name220170719
e0eeb018-194e-4b70-a57d-bac47a97b8eaProduct name120160825
7954898a-d540-405e-aa1d-3553358552e5Product name120150812
55bffd21-17e1-ff02-2e8f-1f9a532b9502Product name220150320
ea069444-e874-4c28-833f-d2f52734ef4dProduct name120150206
041df61b-f8b6-48a6-7b67-411e1412678bProduct name120140508
0ad8bdca-888e-00da-648b-6a4de854a167Product name120140508
433a3439-b8f3-d13a-d2c8-9b221d628d60Product name120140508
59212689-39e5-a976-6d21-882d76d8079aProduct name120140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212Product name120140508
78637fb0-95c8-441f-e4b4-db1274b6f956Product name120140508
df89bd47-2db4-d593-ab37-d11953fd5536Product name120140508
f151007d-265d-9fbe-857d-1d44f1cb76baProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
17089-260-18GUNA-DIUR1 in 1 BOXSOLUTION/ DROPS12
17089-260-18GUNA-DIUR30 mL in 1 BOTTLE, DROPPERSOLUTION/ DROPS302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
17089-260GUNA-DIUR (AMILORIDE - APIS MELLIFERA - BERBERIS VULGARIS FRUIT - HIERACIUM PILOSELLA FLOWERING TOP - HYDROCHLOROTHIAZIDE - SOLIDAGO VIRGAUREA FLOWERING TOP - SPIRONOLACTONE - SUS SCROFA PITUITARY GLAND -) SOLUTION/ DROPS [GUNA SPA]2Current NDC, Legacy NDC, 2 package rows20190405_3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
AMILORIDEACTIVE INGREDIENT7DZO8EB0Z31
APIS MELLIFERAACTIVE INGREDIENT7S82P3R43Z1
BERBERIS VULGARIS FRUITACTIVE INGREDIENT6XEF22AHC31
HIERACIUM PILOSELLA FLOWERING TOPACTIVE INGREDIENT08A7Y81S1P1
HYDROCHLOROTHIAZIDEACTIVE INGREDIENT0J48LPH2TH1
SOLIDAGO VIRGAUREA FLOWERING TOPACTIVE INGREDIENT5405K23S501
SPIRONOLACTONEACTIVE INGREDIENT27O7W4T2321
SUS SCROFA PITUITARY GLANDACTIVE INGREDIENTE8S87O660T1
AMILORIDEACTIVE MOIETY7DZO8EB0Z31
APIS MELLIFERAACTIVE MOIETY7S82P3R43Z1
BERBERIS VULGARIS FRUITACTIVE MOIETY6XEF22AHC31
HIERACIUM PILOSELLA FLOWERING TOPACTIVE MOIETY08A7Y81S1P1
HYDROCHLOROTHIAZIDEACTIVE MOIETY0J48LPH2TH1
SOLIDAGO VIRGAUREA FLOWERING TOPACTIVE MOIETY5405K23S501
SPIRONOLACTONEACTIVE MOIETY27O7W4T2321
SUS SCROFA PITUITARY GLANDACTIVE MOIETYE8S87O660T1
ALCOHOLINACTIVE INGREDIENT3K9958V90M1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
17089-26017089-260-18

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 22 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ALCOHOLALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MELIXIR / ORAL13675 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / ORAL210 mg/1mlExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / ORAL210 mg/1mlExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MTABLET, DELAYED RELEASE / ORALNAExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE / ORAL882 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MELIXIR / ORAL13675 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSYRUP / ORAL21000 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCONCENTRATE / ORAL198 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / ORAL6624 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE / ORAL882 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSYRUP / ORAL21000 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION, CONCENTRATE / ORAL150.68 mg/1mlExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCONCENTRATE / ORAL198 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MTABLET, DELAYED RELEASE / ORALNAExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / ORAL6624 mgExact identifier — unii+route
22 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION, CONCENTRATE / ORAL150.68 mg/1mlExact identifier — unii+route
22 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GUNA-DIURAMILORIDE - APIS MELLIFERA - BERBERIS VULGARIS FRUIT - HIERACIUM PILOSELLA FLOWERING TOP - HYDROCHLOROTHIAZIDE - SOLIDAGO VIRGAUREA FLOWERING TOP - SPIRONOLACTONE - SUS SCROFA PITUITARY GLAND -Guna spa3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe22018-12-21Warnings, Adverse reactionsExact identifier
ndc (package): 17089-260-18
ndc (product): 17089-260
ndc11 (package): 17089026018
spl id: 7e7c2115-72fe-9ca5-e053-2a91aa0ae101
spl set id: 3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.